# Adma Biologics, Inc.: filings

ADMA · Nasdaq · CIK 1368514 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/adma.md) · [Financials](/companies/adma/financials.md) · [Filings](/companies/adma/filings.md) · [Insiders](/companies/adma/insiders.md)

## Reports and events: 392 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 329, 8-K 266, 10-Q 54, SC 13G/A 32, CORRESP 29, 3 22, 144 21, 424B5 18, 10-K 17, SC 13G 17, UPLOAD 16, DEF 14A 14, S-1/A 13, CT ORDER 12, SC 13D/A 12, DEFA14A 10, S-8 9, EFFECT 8, 4/A 7, S-8 POS 7, SC 13D 7, 8-K/A 5, ARS 5, S-3 5, PRE 14A 4, 8-A12B 3, S-1 3, S-3/A 3, 15-12B 2, D 2, SCHEDULE 13G/A 2, SEC STAFF LETTER 2, 10-K/A 1, 144/A 1, 424B1 1, 424B3 1, 424B4 1, 424B7 1, CERTNAS 1, DEF 14C 1, DEFM14A 1, DEFR14A 1, NT 10-K 1, PREM14A 1, S-1MEF 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-05 | 17:16 ET | [10-Q](/filings/0001140361-26-031445.md) | Quarterly report, period 2026-06-30 | 0001140361-26-031445 |
| 2026-08-05 | 16:10 ET | [8-K](/filings/0001140361-26-031423.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-031423 |
| 2026-06-02 | 16:05 ET | [8-K](/filings/0001140361-26-023705.md) | 5.07 Shareholder vote results | 0001140361-26-023705 |
| 2026-05-06 | 17:16 ET | [10-Q](/filings/0001140361-26-019336.md) | Quarterly report, period 2026-03-31 | 0001140361-26-019336 |
| 2026-05-06 | 16:10 ET | [8-K](/filings/0001140361-26-019295.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-019295 |
| 2026-05-04 | 07:05 ET | [8-K](/filings/0001140361-26-018667.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-018667 |
| 2026-04-15 | 16:30 ET | [DEF 14A](/filings/0001140361-26-014799.md) | Proxy statement, period 2026-06-02 | 0001140361-26-014799 |
| 2026-03-27 | 07:05 ET | [8-K](/filings/0001140361-26-011569.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-011569 |
| 2026-03-02 | 07:05 ET | [8-K](/filings/0001140361-26-007230.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-007230 |
| 2026-02-25 | 17:16 ET | [10-K](/filings/0001140361-26-006815.md) | Annual report, period 2025-12-31 | 0001140361-26-006815 |
| 2026-02-25 | 16:11 ET | [8-K](/filings/0001140361-26-006781.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-26-006781 |
| 2026-01-12 | 08:20 ET | [8-K](/filings/0001140361-26-000906.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-000906 |
| 2025-11-05 | 17:15 ET | [10-Q](/filings/0001140361-25-040578.md) | Quarterly report, period 2025-09-30 | 0001140361-25-040578 |
| 2025-11-05 | 16:11 ET | [8-K](/filings/0001140361-25-040539.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-040539 |
| 2025-08-06 | 17:15 ET | [10-Q](/filings/0001140361-25-029177.md) | Quarterly report, period 2025-06-30 | 0001140361-25-029177 |
| 2025-08-06 | 16:11 ET | [8-K](/filings/0001140361-25-029143.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001140361-25-029143 |
| 2025-06-04 | 17:25 ET | [8-K](/filings/0001140361-25-021440.md) | 5.07 Shareholder vote results | 0001140361-25-021440 |
| 2025-05-07 | 17:15 ET | [10-Q](/filings/0001140361-25-017747.md) | Quarterly report, period 2025-03-31 | 0001140361-25-017747 |
| 2025-05-07 | 16:12 ET | [8-K](/filings/0001140361-25-017704.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-017704 |
| 2025-04-28 | 07:06 ET | [8-K](/filings/0001140361-25-015881.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-015881 |
| 2025-04-15 | 16:30 ET | [DEF 14A](/filings/0001140361-25-013967.md) | Proxy statement, period 2025-06-04 | 0001140361-25-013967 |
| 2025-03-18 | 16:12 ET | [10-K](/filings/0001140361-25-009257.md) | Annual report, period 2024-12-31 | 0001140361-25-009257 |
| 2025-03-03 | 16:06 ET | [8-K](/filings/0001140361-25-006745.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-006745 |
| 2025-02-21 | 17:25 ET | [8-K](/filings/0001140361-25-005489.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-25-005489 |
| 2025-01-13 | 07:10 ET | [8-K](/filings/0001140361-25-000871.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-000871 |
| 2025-01-13 | 07:05 ET | [8-K](/filings/0001140361-25-000870.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-000870 |
| 2025-01-02 | 16:06 ET | [8-K](/filings/0001140361-25-000073.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-25-000073 |
| 2024-12-20 | 07:05 ET | [8-K](/filings/0001140361-24-050002.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-050002 |
| 2024-11-21 | 16:30 ET | [8-K](/filings/0001140361-24-047487.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-24-047487 |
| 2024-11-07 | 17:00 ET | [10-Q](/filings/0001140361-24-045693.md) | Quarterly report, period 2024-09-30 | 0001140361-24-045693 |
| 2024-11-07 | 16:10 ET | [8-K](/filings/0001140361-24-045657.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-045657 |
| 2024-10-31 | 17:25 ET | [8-K](/filings/0001140361-24-044808.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001140361-24-044808 |
| 2024-10-10 | 09:29 ET | [8-K](/filings/0001140361-24-043250.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-043250 |
| 2024-10-09 | 17:25 ET | [8-K](/filings/0001140361-24-043222.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001140361-24-043222 |
| 2024-08-14 | 09:05 ET | [8-K](/filings/0001140361-24-037184.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-037184 |
| 2024-08-08 | 17:00 ET | [10-Q](/filings/0001140361-24-036432.md) | Quarterly report, period 2024-06-30 | 0001140361-24-036432 |
| 2024-08-08 | 16:10 ET | [8-K](/filings/0001140361-24-036399.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-036399 |
| 2024-07-26 | 17:15 ET | [8-K](/filings/0001140361-24-034440.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-24-034440 |
| 2024-06-28 | 16:34 ET | [8-K](/filings/0001140361-24-031778.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001140361-24-031778 |
| 2024-06-04 | 16:05 ET | [8-K](/filings/0001140361-24-028800.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001140361-24-028800 |
| 2024-05-17 | 09:00 ET | [8-K](/filings/0001140361-24-026601.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-026601 |
| 2024-05-09 | 17:01 ET | [10-Q](/filings/0001140361-24-025226.md) | Quarterly report, period 2024-03-31 | 0001140361-24-025226 |
| 2024-05-09 | 16:06 ET | [8-K](/filings/0001140361-24-025173.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-025173 |
| 2024-04-15 | 16:31 ET | [DEF 14A](/filings/0001140361-24-019868.md) | Proxy statement, period 2024-06-04 | 0001140361-24-019868 |
| 2024-04-02 | 17:16 ET | [8-K](/filings/0001140361-24-017331.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-24-017331 |
| 2024-03-11 | 16:05 ET | [8-K](/filings/0001140361-24-012605.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-012605 |
| 2024-03-05 | 16:05 ET | [8-K](/filings/0001140361-24-011399.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-011399 |
| 2024-02-28 | 17:01 ET | [10-K](/filings/0001140361-24-010147.md) | Annual report, period 2023-12-31 | 0001140361-24-010147 |
| 2024-02-28 | 16:21 ET | [8-K](/filings/0001140361-24-010100.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-010100 |
| 2024-02-28 | 16:15 ET | [8-K](/filings/0001140361-24-010088.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-010088 |

Page 1 of 8. [Older](/companies/adma/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.